rs4410790 — AHR

Of all the genetic variants associated with how much caffeine people habitually consume, rs4410790 is the single strongest signal ever detected in a genome-wide study. Located 54 kilobases upstream of the aryl hydrocarbon receptor (AHR) gene on chromosome 7, this regulatory variant does not change any protein sequence — instead, it appears to alter how strongly the AHR gene is expressed, which in turn determines how efficiently the body ramps up CYP1A2¹¹ CYP1A2
The cytochrome P450 1A2 enzyme, responsible for approximately 95% of the primary metabolism of caffeine in the liver, the enzyme responsible for clearing caffeine from the bloodstream.

The result is a striking population-level pattern: people who carry the C allele at rs4410790 tend to drink substantially more coffee and consume more caffeine than those who carry two T alleles. The difference between the extreme genotypes (TT vs CC) averages around 44 mg of caffeine per day — roughly half a cup of coffee — driven by how quickly or slowly each person clears the drug and therefore how much they need to feel its effects.

AHR is a ligand-activated transcription factor²² ligand-activated transcription factor
A protein that sits dormant in the cytoplasm until it binds a chemical signal, then travels to the nucleus and activates target genes that controls the expression of several detoxification enzymes, including CYP1A1 and CYP1A2. When AHR is activated by a ligand (caffeine itself is a weak AHR ligand; stronger activators include dietary indoles from cruciferous vegetables and environmental pollutants like dioxins), it partners with ARNT, binds to xenobiotic response elements (XREs)³³ xenobiotic response elements (XREs)
DNA sequence motifs, consensus 5'-TNGCGTG-3', in the promoters of AHR target genes in the CYP1A2 promoter, and drives transcription.

rs4410790 sits in a genomic region that influences AHR gene expression itself. The precise molecular mechanism remains under investigation, but evidence points to epigenetic regulation: the variant is associated with differential methylation of CpG sites in the AHR regulatory region, with the TT genotype linked to higher AHR methylation (and potentially lower AHR expression in relevant tissues) compared with C allele carriers. Lower AHR expression would mean reduced capacity to induce CYP1A2, slowing caffeine clearance and reducing the tolerance-building drive toward higher intake.

The C allele is proposed to increase AHR's transcriptional activity, leading to higher basal and inducible CYP1A2 levels. Faster caffeine clearance means the stimulant effect wears off sooner, and pharmacokinetic tolerance⁴⁴ pharmacokinetic tolerance
The tendency to increase dose as the body clears a drug more efficiently, requiring more to achieve the same effect develops more readily, driving higher habitual consumption.

Caffeine consumption GWAS. The landmark genome-wide meta-analysis by Cornelis et al.⁵⁵ genome-wide meta-analysis by Cornelis et al.
Cornelis MC et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet, 2011 pooled data from 47,341 Europeans across five US population-based studies and identified rs4410790 as the peak signal at the AHR locus (P = 2.4 × 10^-19, beta = -0.15, SE = 0.02 for the T allele). Controlling for age, sex, smoking status, and genetic ancestry, individuals homozygous for the T allele consumed on average 44 mg less caffeine per day than CC homozygotes. Only one other locus reached genome-wide significance — the CYP1A1-CYP1A2 region at 15q24 (P = 5.2 × 10^-14) — establishing that the AHR regulatory axis and CYP1A2 enzymatic axis are the two primary genetic drivers of caffeine consumption patterns in the population.

Replication in ethnically diverse populations. Josse et al.⁶⁶ Josse et al.
Josse AR et al. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption. Am J Clin Nutr, 2012 replicated the AHR association in a Costa Rican case-control cohort, finding that high caffeine consumers (>400 mg/day) were significantly more likely to carry the C allele at rs4410790 (OR = 1.41, 95% CI 1.04–1.92) compared with low consumers (<100 mg/day). Notably, the association was strongest in nonsmokers and in adults over age 57, suggesting that smoking and aging independently modify CYP1A2 inducibility in ways that dilute or amplify the genetic signal.

IgG and immune signaling. Beyond caffeine, a Korean cross-sectional study Park et al.⁷⁷ Park et al.
Park J et al. AHR rs4410790 genotype and IgG levels: Effect modification by lifestyle factors. PLoS One, 2023 (n = 168) found that TT homozygotes had significantly elevated serum IgG levels compared with TC and CC carriers, independent of caffeine consumption. The authors propose that rs4410790 affects AHR methylation, and that AHR's regulatory role in the immune system — mediating T-cell differentiation, IgA/IgG class switching, and gut barrier signaling — is being modulated independently of the caffeine metabolism axis. The effect was amplified by frequent alcohol consumption and BMI ≥ 23 kg/m², pointing to gene-lifestyle interactions in immune regulation.

The primary clinical relevance of rs4410790 is as a modifier of caffeine sensitivity and habitual intake. TT carriers tend to have lower CYP1A2 inducibility through the AHR pathway, meaning caffeine accumulates in their system more readily. They consume less caffeine on average — but this also means that a given dose of caffeine stays active longer. If a TT carrier drinks coffee in the afternoon, the caffeine is more likely to still be circulating at bedtime, disrupting sleep architecture.

For CC homozygotes, the picture is inverted: faster clearance supports higher habitual consumption, and caffeine is less likely to impair sleep at moderate doses. However, this faster-clearance phenotype also means caffeine withdrawal (headaches, fatigue) may be more pronounced when intake is reduced, and the drive to maintain high daily intake can become entrenched.

Since AHR also regulates CYP1A2 responses to polycyclic aromatic hydrocarbons (PAHs)⁸⁸ polycyclic aromatic hydrocarbons (PAHs)
Cancer-promoting compounds formed by incomplete combustion, found in tobacco smoke and charred food and other environmental inducers, rs4410790 genotype may also influence individual sensitivity to these compounds — though this has not been specifically studied for this regulatory variant.

The most important functional interaction is with rs762551 in CYP1A2. AHR (upstream regulator) and CYP1A2 (the enzyme itself) act in series: AHR controls how readily CYP1A2 is expressed, and CYP1A2's own activity determines actual caffeine clearance rate. An individual who carries the T allele at rs4410790 (lower AHR-driven CYP1A2 induction) and also carries the C allele at rs762551 (the CYP1A2 slow-metabolizer variant) is expected to have compounded reductions in caffeine clearance capacity.

The related coding variant rs2066853 in the AHR transactivation domain is a second, independent signal at the same gene. While rs4410790 affects AHR expression level, rs2066853 affects receptor protein function. Their combined effect on CYP1A2 regulation is plausible but has not been formally quantified in human studies.

AHR's interaction with the circadian clock (sequestering BMAL1 from CLOCK, suppressing Per1) is described in the rs2066853 entry and applies to AHR signaling broadly. The rs4410790 variant modulates the overall level of AHR activity in the cell, potentially influencing the magnitude of this circadian interference.